We identify inactivation of BRCA1, BRCA2, RAD51C, and PALB2 as the most frequent genetic cause of HRD pan-cancer in both primary and metastatic cancer, with the latter two genes resulting in the same mutational footprints as BRCA2 (consistent with the findings of recent studies in breast cancer11,12). This evidence concerns the gene BRCA1 and cancer.